🕵️ CVS Health Corp ($CVS)
SEC insider & ownership activity, last 12 months · CIK 64803 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. BlackRock, Inc. added 7.1% → 8.3%. No red-flag 8-Ks in the window.
🚨 3 signals active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, value withheld pending verification (4 lots) · 2 sellers, $359.0M (9 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Robbins Larry | 0 | – | 8 | $352.7M | May 21, 2026 |
| Tilak Mandadi | 0 | – | 1 | $6.2M | May 8, 2026 |
| Heidi B. Capozzi | 3 | value withheld pending verification | 0 | – | Oct 23, 2024 |
| Steven H. Nelson | 1 | $1K | 0 | – | Jan 23, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.3% | 13G | Jul 16, 2025 | filing ↗ | |
| Vanguard Capital Management | 7.5% | 13G | Apr 29, 2026 | filing ↗ | |
| Capital World Investors | 5.5% | 13G | May 13, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Roger N. Farah | $264K | May 21, 2026 | filing ↗ |
| Aguirre Fernando | $214K | May 20, 2026 | filing ↗ |
| Aguirre Fernando | $2.8M | May 20, 2026 | filing ↗ |
| Tilak Mandadi | $6.2M | May 8, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Aug 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2026 | filing ↗ |
| Earnings (2.02) | Aug 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 14, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 14, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 18, 2026 | filing ↗ |
| Earnings (2.02) | Feb 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 9, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 9, 2025 | filing ↗ |
| Other events (8.01) | Nov 20, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 20, 2025 | filing ↗ |
| Earnings (2.02) | Oct 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 29, 2025 | filing ↗ |
| Other events (8.01) | Sep 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 22, 2025 | filing ↗ |